NDASUBCUTANEOUSSOLUTION
Approved
Sep 2018
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
6
Data completeness
4/8 — Partial
XYOSTED (AUTOINJECTOR) (testosterone enanthate) by Antares Therapeutics is clinical pharmacology endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. First approved in 2018.
Drug data last refreshed 12h ago · AI intelligence enriched 1mo ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
XYOSTED is a subcutaneous autoinjector formulation of testosterone enanthate, a synthetic androgen used for testosterone replacement therapy in hypogonadal men. It works by restoring endogenous androgen levels to support development and maintenance of male sex characteristics, muscle mass, bone density, and red blood cell production. The ester formulation enables depot delivery with dosing intervals of 2–4 weeks.
Peak9.8 years to LOE
Product is at peak lifecycle stage with established market presence; brand teams focus on market consolidation and lifecycle management initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Endogenous androgens are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics. These effects include growth and maturation of prostate, seminal vesicles, penis, and scrotum; development of male hair…
Worked on XYOSTED (AUTOINJECTOR) at Antares Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.